Martin Kerschensteiner is the Chair for Neurosciences and Clinical Neuroimmunology and the Director of the Institute of Clinical Neuroimmunology at the Ludwig-Maximilians University in Munich.
He received his medical training at the RWTH Aachen and Ludwig-Maximilians Universitiy (LMU) in Munich and performed his MD thesis at the Max-Planck Institute of Neurobiology. He received clinical training at the Department of Neurology of the LMU Munich and postdoctoral training at the Brain Research Institute of ETH Zurich, at the Washington University in St. Louis and at Harvard University. After returning to Germany as a junior group leader, he was promoted to Associate Professor in 2008 and to Full Professor and Chair of the Institute of Clinical Neuroimmunology at LMU Munich in 2013.
Professor Kerschensteiner`s research focuses on understanding the mechanisms of tissue damage and repair in neuroinflammatory conditions and the development of neuroprotective and regenerative treatment strategies. He is the deputy director of the Biomedical Center of the LMU Munich as well as member of the executive boards of the Collaborative Research Center on Multiple Sclerosis (SFB/Tr128), the German Competence Network Multiple Sclerosis (KKNMS) and the Munich Excellence Cluster for Systems Neurology (SyNergy).